Home › Hidradenitis Suppurativa › Ohio
Hidradenitis Suppurativa clinical trials in Ohio
5 studies for Hidradenitis Suppurativa are looking for participants at sites in Ohio.
Cities in Ohio
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- Optima Research Boardman, Boardman
- Apex Clinical Research Center LLC, Mayfield Heights
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 28, 2026 · NCT07665437Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
- Clinical Site 10, Mayfield Heights
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07828860Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US028, Bexley
- Investigative Site US025, Cincinnati
- Investigative Site US073, Columbus
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06855498A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
- Apex Clinical Research Center, LLC., Mayfield Heights
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 6, 2026 · NCT07244263The Ohio State University Dermatology Biorepository
- OSU Dermatology West, Columbus
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Feb 27, 2026 · NCT03146676From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.